Work

Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: A cell line study in four glioblastoma multiforme (GBM) cell lines

FWCI: 2.72
Cites: 40
Cited by: 31
Related to: 10